Under construction – not a live service
Sign in

2024-516520-34-00Active, not recruitingPhase 1

Study of GS-0151 in Participants With Rheumatoid Arthritis

Source: EU CTIS (euclinicaltrials.eu) · Last updated 16 Jun 2026

Next steps

Status (registry)
Active, not recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
39 (estimated)
First submitted
28 Apr 2025
Start date
17 Nov 2025
Lead sponsor
Gilead Sciences Inc.
EU CT number
2024-516520-34-00

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 39
  • 15 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (15)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University Hospital Cologne AöRCologneGermanyActive, not recruiting
Krankenhaus Porz am Rhein gGmbHCologneGermanyActive, not recruiting
MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbHHamburgGermanyActive, not recruiting
LMU Klinikum Muenchen AöRMunichGermanyActive, not recruiting
Area Sanitaria Da Coruna E CeeA CorunaSpainActive, not recruiting
Hospital del MarBarcelonaSpainActive, not recruiting
Hospital Universitario Ramón y CajalMadridSpainActive, not recruiting
Parc Tauli Hospital UniversitariSabadellSpainActive, not recruiting
Hospital Quironsalud Infanta LuisaSevillaSpainActive, not recruiting
Clinicmed Daniluk Nowak Sp. k.BialystokPolandActive, not recruiting
FutureMeds Sp. z o.o.GdyniaPolandActive, not recruiting
Futuremeds Sp. z o.o.LodzPolandActive, not recruiting
Medicover Integrated Clinical Services Sp. z o.o.TorunPolandActive, not recruiting
Futuremeds Sp. z o.o.WarsawPolandActive, not recruiting
Futuremeds Sp. z o.o.WroclawPolandActive, not recruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.